This article was originally published in The Tan Sheet
Indianapolis-based Kingswood Labs initiates nationwide recall of Moi-Stir oral swabsticks due to mold contamination. Kingswood has informed FDA and is notifying distributors and customers to arrange for immediate return of all recalled product. The swabs provide a saliva supplement and were distributed to hospitals, wholesalers, pharmacies, doctors, dentists and consumers. "Some of the swabsticks have been found to contain molds including aspergillus and penicillium, which could result in respiratory infections," the firm reports...
You may also be interested in...
Medicinal products authorities will consider a medtech notified body opinion on the device element of a drug/device combination product. A new position paper explains how roles and responsibilities are shared between medtech and medicinal product experts.
A South Korean pharma firm is set to soon begin pivotal clinical trials for a hyperimmune globulin for the treatment of COVID-19 patients and plans to commercialize the product this year, with a hope of outrunning rivals including Takeda.
Royal Philips will make 43,000 medical ventilators by year-end for use in the US and make 2,500 more for the Strategic National Stockpile in a deal with the US government worth $646.7m. See what Philips’ CEO Frans van Houten said about it here.